View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
June 22, 2020updated 22 Mar 2022 6:14am

Indian researchers develop software for cervical cancer diagnosis

Researchers from the Institute of Advanced Study in Science and Technology (IASST) in India have developed a fully automated software-based solution for the detection of cervical cancer.

Researchers from the Institute of Advanced Study in Science and Technology (IASST) in India have developed a fully automated software-based solution for the detection of cervical cancer.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

The software uses Pap smear images to detect abnormal growth or development of tissues in the cervix.

Pap Smear is a widely used technique for the early detection of cervical cancer. The diagnosis involves analysing the slides prepared from the smear collections, under a microscope.

The researchers were quoted by Times of India as saying: “We put together a database of two types of indigenous Pap smear images databases, one each for conventional and Liquid Based Cytology (LBC) and used it to create algorithms with the images of different qualities, being prepared by different technicians and captured from different microscopes. The algorithms helped develop robust software to detect cervical cancer.”

The group also employed the Bethesda system for Pap Smear diagnosis and adopted two artificial intelligence (AI) approaches, namely machine learning and deep learning, for the development of the software.

IASST operator The Department of Science and Technology (DST) told the publication: “The team has developed a novel classification algorithm, with 98.8% accuracy, which can identify the precancerous and cancer lesions while precisely localising the cervical cells, removing the debris including overlapping cells and then finally classifying them based on the Bethesda system nomenclature, to maintain uniformity with the current reporting system.”

The researchers intend to launch a pocket-friendly diagnostic kit after conducting substantial field trials. It will be hosted and marketed on a web-based platform.

Cervical cancer is one of the most prevalent cancers among women in India, particularly among women in the north-eastern region of the country.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network